| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |